Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 6.16 USD -5.23% Market Closed
Market Cap: 175m USD

Intrinsic Value

The intrinsic value of one ARCT stock under the Base Case scenario is hidden USD. Compared to the current market price of 6.16 USD, Arcturus Therapeutics Holdings Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARCT Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Arcturus Therapeutics Holdings Inc

Intrinsic Value History
Dive into the past to invest in the future

ARCT looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ARCT is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ARCT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ARCT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Arcturus Therapeutics Holdings Inc.

Explain Valuation
Compare ARCT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ARCT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Arcturus Therapeutics Holdings Inc

Current Assets 249.2m
Cash & Short-Term Investments 180.4m
Receivables 8m
Other Current Assets 60.9m
Non-Current Assets 33.1m
PP&E 31.3m
Other Non-Current Assets 1.9m
Current Liabilities 31.7m
Accounts Payable 5.5m
Accrued Liabilities 19.4m
Other Current Liabilities 6.8m
Non-Current Liabilities 26.1m
Other Non-Current Liabilities 26.1m
Efficiency

Free Cash Flow Analysis
Arcturus Therapeutics Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Arcturus Therapeutics Holdings Inc

Revenue
97.6m USD
Operating Expenses
-175.9m USD
Operating Income
-78.3m USD
Other Expenses
11.6m USD
Net Income
-66.7m USD
Fundamental Scores

ARCT Profitability Score
Profitability Due Diligence

Arcturus Therapeutics Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Arcturus Therapeutics Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ARCT Solvency Score
Solvency Due Diligence

Arcturus Therapeutics Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
hidden
Solvency
Score

Arcturus Therapeutics Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARCT Price Targets Summary
Arcturus Therapeutics Holdings Inc

Wall Street analysts forecast ARCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARCT is 32.77 USD with a low forecast of 9.09 USD and a high forecast of 71.4 USD.

Lowest
Price Target
9.09 USD
48% Upside
Average
Price Target
32.77 USD
432% Upside
Highest
Price Target
71.4 USD
1 059% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Arcturus Therapeutics Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ARCT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ARCT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ARCT stock?

The intrinsic value of one ARCT stock under the Base Case scenario is hidden USD.

Is ARCT stock undervalued or overvalued?

Compared to the current market price of 6.16 USD, Arcturus Therapeutics Holdings Inc is hidden .

Back to Top